Aarti Pharmalabs Strengthens Partnership with Bandodkars via Addendum

Aarti Pharmalabs Limited has executed an addendum to its agreement with Bandodkars, marking a significant step in their ongoing collaboration. This move underscores Aarti Pharmalabs' commitment to enhancing its partnerships and expanding its capabilities in the pharmaceutical sector. The company specializes in manufacturing active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, serving global pharmaceutical companies. The addendum is part of Aarti Pharmalabs' strategy to bolster its position in the industry through strategic agreements.

 

Source: Marketscreener